首页 | 本学科首页   官方微博 | 高级检索  
     

来氟米特治疗难治性结缔组织病15例疗效观察
引用本文:徐峰,李锋,冯树芳. 来氟米特治疗难治性结缔组织病15例疗效观察[J]. 临床皮肤科杂志, 2004, 33(11): 697-699
作者姓名:徐峰  李锋  冯树芳
作者单位:复旦大学华山医院皮肤科,上海,200040;复旦大学华山医院皮肤科,上海,200040;复旦大学华山医院皮肤科,上海,200040
摘    要:目的:观察来氟米特治疗难治性结缔组织病的疗效。方法:应用小剂量来氟米特(20mg/d)开放性治疗15例难治性结缔组织病患者,包括系统性红斑狼疮(10例)、皮肌炎(4例)、白塞病(1例)。结果:对于常规治疗无效的顽同难治性患者,应用小剂量来氟米特疗效显著,能控制病情,减少糖皮质激素用量。结论:来氟米特为难治性结缔组织病提供了一种较好的治疗方案。

关 键 词:红斑狼疮  系统性  皮肌炎  白塞病  来氟米特
文章编号:1000-4963(2004)11-0697-03
修稿时间:2004-05-08

Clinical investigation of leflunomide in the treatment of refractory connective diseases
XU Feng,LI Feng,FENG Shu-fang. Clinical investigation of leflunomide in the treatment of refractory connective diseases[J]. Journal of Clinical Dermatology, 2004, 33(11): 697-699
Authors:XU Feng  LI Feng  FENG Shu-fang
Abstract:Objective: To study the efficacy of leflunomide in the treatment of refractory connective diseases. Methods: An open clinical trial was performed since 2002. 15 patients with refractory connective diseases were treated with low-dose leflunomide including 10 cases of SLE, 4 cases of DM, and 1 case of Behcet's disease. Results: Small dosage of leflunomide was exceptionally effective in the treatment of refractory connective diseases. It could well control the disease activity and reduce the dosage of systemic cortico steroids. Conclusion: leflunomide provides a good alternative for the treatment of refractory connective diseases.
Keywords:lupus erythematosus   systemic  dermatomyositis  Behret' s disease  leflunomide
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号